Individualized risk assessment for use of hormone therapy in people with sickle cell disease

Res Pract Thromb Haemost. 2023 Dec 15;8(1):102297. doi: 10.1016/j.rpth.2023.102297. eCollection 2024 Jan.

Maureen K Baldwin^{1

2}, Bethany Samuelson Bannow^{1

2}, Rachel P Rosovsky^{1

3}, Nancy Sokkary^{1

4}, Lakshmi V Srivaths^{1

5}

¹ Women and Girls with Blood Disorders Learning Action Network, Montclair, New Jersey, USA.
² Oregon Health & Science University, Portland, Oregon, USA.
³ Division of Hematology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Obstetrics and Gynecology, Children's Healthcare of Atlanta/Emory School of Medicine, Atlanta, Georgia, USA.
⁵ Department of Pediatrics, Gulf States Hemophilia and Thrombophilia Center, McGovern Medical School at the University of Texas Health Science Center, Houston, Texas, USA.

No abstract available

Publication types